We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

81 hedge funds and large institutions have $339M invested in Enanta Pharmaceuticals in 2014 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

3,333% more call options, than puts

Call options by funds: $412K | Put options by funds: $12K

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

158% more capital invested

Capital invested by funds: $132M → $339M (+$208M)

123% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 13

23% more funds holding

Funds holding: 66 → 81 (+15)

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

Holders
81
Holders Change
+15
Holders Change %
+22.73%
% of All Funds
2.34%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.09%
New
29
Increased
25
Reduced
21
Closed
13
Calls
$412K
Puts
$12K
Net Calls
+$400K
Net Calls Change
+$400K

Top Buyers

1
RCM
RA Capital Management
Massachusetts
+$56M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$42.5M
3
EAM
Eagle Asset Management
Florida
+$19.2M
4
CCM
Consonance Capital Management
New York
+$14.6M
5
ICRM
Insight Capital Research & Management
California
+$7.51M

Top Sellers

1
Franklin Resources
Franklin Resources
California
-$8.16M
2
AP
AlpInvest Partners
Netherlands
-$4.49M
3
SM
Sabby Management
Florida
-$3.12M
4
Millennium Management
Millennium Management
New York
-$2.93M
5
Barclays
Barclays
United Kingdom
-$2.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
76
AllianceBernstein
Tennessee
$3K – – –
GC
77
Globeflex Capital
California
$2K – – –
PTC
78
Private Trust Company
Ohio
$1K +$763 +21 New
Group One Trading
79
Group One Trading
Illinois
$1K +$799 +22 New
Manulife (Manufacturers Life Insurance)
80
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$133 +$116K +3,205 +2,995%
Franklin Resources
81
Franklin Resources
California
– -$8.16M -299,000 Closed
AP
82
AlpInvest Partners
Netherlands
– -$4.49M -164,500 Closed
Millennium Management
83
Millennium Management
New York
– -$2.93M -107,519 Closed
SM
84
Sabby Management
Florida
– -$3.12M -85,946 Closed
Renaissance Technologies
85
Renaissance Technologies
New York
– -$1.75M -64,300 Closed
Two Sigma Investments
86
Two Sigma Investments
New York
– -$1.34M -49,148 Closed
IHM
87
Iguana Healthcare Management
New York
– -$1.09M -40,000 Closed
SFM
88
Sphera Funds Management
Israel
– -$690K -25,292 Closed
Prudential Financial
89
Prudential Financial
New Jersey
– -$411K -15,070 Closed
EMG
90
Ellington Management Group
Connecticut
– -$314K -11,500 Closed
CAM
91
Cormorant Asset Management
Massachusetts
– -$273K -10,000 Closed
Goldman Sachs
92
Goldman Sachs
New York
– -$260K -9,541 Closed
TAM
93
Tocqueville Asset Management
New York
– -$41K -1,500 Closed
U
94
UBS
Switzerland
– -$10K -276 -97%
1 2 3
4

ENTA Hedge Fund Activity: Q1 2014 in Review

81 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q1 2014, worth a combined $339M — up 158% from $132M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ENTA positions and 13 closed out — a net gain of 16 holders — while 25 added to existing stakes and 21 trimmed.

The largest buyer was RA Capital Management, opening a new position worth an estimated $56M. The largest seller was Franklin Resources, exiting entirely with an estimated $8.16M sold.

  • 81 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q1 2014, up from 66 in Q4 2013.
  • Funds reported $339M of Enanta Pharmaceuticals stock for Q1 2014, up 158% quarter-over-quarter.
  • 29 funds opened new Enanta Pharmaceuticals positions in Q1 2014 and 13 closed out, a net change of +16 holders.
  • The largest Enanta Pharmaceuticals buyer in Q1 2014 was RA Capital Management, an estimated $56M added.
  • The largest Enanta Pharmaceuticals seller in Q1 2014 was Franklin Resources, an estimated $8.16M sold.

Based on aggregated 13F filings for Q1 2014.